1 Min Read
May 22 (Reuters) - Thrombogenics Nv
* Strategic review is ongoing. An update will be provided in due course
* Cash of eur 156.9 million on hand at end of March 2014, compared to eur 172.4 million at end of December 2013 Further company coverage:
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2017 Reuters. All Rights Reserved.